Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
Paris, France and Camberley, UK - 26 April 2022 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on its ongoing dispute with the Department of Health and Social Care ("DHSC").
On 9 April 2021, Novacyt announced it was in dispute with the DHSC regarding its second supply contract, announced on 29 September 2020. On 25 April 2022, the Company was notified that the DHSC has now issued a claim against Primerdesign Ltd and Novacyt S.A. for £134.6m relating to this contract. The claim amount is broadly in line with the disputed Q4 2020 revenue, as previously announced by the Company.
The Company continues to believe it has strong grounds to defend the claim and assert its contractual rights, including in relation to recovering outstanding sums due from the DHSC.
The Company is unable to provide further comment at this time due to the ongoing nature of this claim but will provide further updates as appropriate.
I somewhat agree that it’s not ideal to be happy about the sp going up due to a new variety. However the reality is that’s it has happened so maybe take a chill pill. No one has control of these things.
With Covid my businesses have lost roughly £200,000 so if I make a small buck from NCYT, I have every right to be some what pleased from a terrible situation.
AVCT
· Cash and short-term deposit balances at 31 December 2020 of £47.9 million (31 December 2019: £8.8 million)
NCYT
· The Company's cash position at 31 December 2020 was €101 million (£91.8 million), compared to €1.8 million (£1.6 million) at 31 December 2019 and €19.7 million (£18.0 million) at 30 June 2020
We have DOUBLE the cash in the bank.
Honestly. Its crazy the MC difference.
AVCT has released their RNS this morning with the following:
· Revenues of £3.6 million for year ended 31 December 2020 (17-month period to 31 December 2019: £5.5 million)
· Operating loss of £21.3 million for year ended 31 December 2020 (17-month period to 31 December 2019: £18.0 million)
Their MC is over £600m
Our turnover was over 50 times that and our market cap is £278...
Bizarre